Health Sciences Group, Inc.

HESG

US42223A1007

Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets 11:13:28 24/04/2024 pm IST			5-day change	1st Jan Change
0.000001 ^USD	-.--%		-.--%	-.--%

2013	Zenetek Completes Joint Venture Agreement With Health Sciences Group, Inc. to Fund Medical Marijuana Social Media/Mobile Apps Development	CI
2013	InternetArray, Inc. Collaborates with Health Sciences Group, Inc. to Fund Medical Marijuana Social Media/Mobile Apps Development	CI

Health Sciences To Acquire Cannabis Dispensary

December 07, 2012 at 10:30 am IST

Health Sciences Group, Inc. is seeking acquisitions. Health Sciences is planning to acquire a cannabis dispensary based in California in order to expand its products and services.

Latest news about Health Sciences Group, Inc.

Zenetek Completes Joint Venture Agreement With Health Sciences Group, Inc. to Fund Medical Marijuana Social Media/Mobile Apps Development	02/13/02	CI
InternetArray, Inc. Collaborates with Health Sciences Group, Inc. to Fund Medical Marijuana Social Media/Mobile Apps Development	31/13/31	CI
Health Sciences To Acquire Cannabis Dispensary	07/12/07	CI

Chart Health Sciences Group, Inc.

Duration

Period

More charts

Health Sciences Group, Inc. identifies, develops and commercializes products and functional food ingredients derived from natural sources to provide consumers and healthcare professionals with preventive healthcare alternatives. The Company has two operating subsidiaries: BioSelect Innovations, Inc. and Swiss Research, Inc. BioSelect Innovations has developed a number of product formulations. These patents address the integration of selective traditional over-the-counter generic drugs with complementary alternative medications, such as vitamins, herbs and other natural nutraceutical supplements. Swiss Research is a diet and nutrition products company, which markets and sells Shugr, a zero-calorie and diabetic safe sugar substitute with the look, taste and baking qualities of cane sugar. The Company will launch its new product, Sequesterol Advance Cardio Formula in April 2006.

Sector

Biotechnology & Medical Research

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
HEALTH SCIENCES GROUP, INC.	-.--%	20.51K
IQVIA HOLDINGS INC.	-0.09%	42.12B
LONZA GROUP AG	+49.62%	42.05B
CELLTRION, INC.	-4.96%	29.18B
ICON PUBLIC LIMITED COMPANY	+11.18%	26.02B
ALNYLAM PHARMACEUTICALS, INC.	-21.95%	18.9B
BIO-TECHNE CORPORATION	+8.61%	13.21B
UNITED THERAPEUTICS CORPORATION	+24.73%	12.17B
MEDPACE HOLDINGS, INC.	+28.31%	12.16B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-6.26%	11.42B

Other Biotechnology & Medical Research

Health Sciences Group, Inc.

Equities

HESG

US42223A1007

Biotechnology & Medical Research

Health Sciences To Acquire Cannabis Dispensary

Latest news about Health Sciences Group, Inc.

Chart Health Sciences Group, Inc.

Company Profile

Sector Other Biotechnology & Medical Research